Medical Cannabis market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Medical Cannabis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Tetrahydrocannabinol (THC) Cannabidiol (CBD) Segment by Application Pain Arthritis Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications) Others By Company BOL Pharma Tilray Medreleaf Corporation Aurora Cannabis, Inc Canopy Growth Corporation Insys Therapeutics, Inc Aphria, Inc MGC Pharmaceuticals Limited GW Pharmaceuticals, plc Medical Marijuana Inc Medipharm Labs By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E
1 Study Coverage 1.1 Medical Cannabis Product Introduction 1.2 Market by Type 1.2.1 Global Medical Cannabis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Tetrahydrocannabinol (THC) 1.2.3 Cannabidiol (CBD) 1.3 Market by Application 1.3.1 Global Medical Cannabis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Pain
